Table 1.
Subject Population |
Type/frequency of NSAID |
Outcome Measure(s) Used |
Number of Subjects |
Diagnosis Period |
Follow-up Period |
---|---|---|---|---|---|
Iowa Women’s Health Study, Postmenopausal women with invasive breast cancer (Blair et al. 2007) | All NSAIDs; any frequency | Breast cancer and all-cause mortality | 591 | 1986–1992 | 1992–2001 |
Life After Cancer Epidemiology (LACE) Study, Pre- and postmenopausal women with invasive breast cancer (Kwan et al. 2007) | All NSAIDs; ≥3 days/week | Breast cancer recurrence | 2292 | 1997–2000 | 2000–2006 |
Nurse’s Health Study, Pre- and postmenopausal women with stage I–III breast cancer (Holmes et al. 2010) | Aspirin only; 1, 2–5, and 6–7 days/week | Breast cancer mortality and distant recurrence | 4164 | 1976–2002 | 1980–2006 |